04.15.26 -- Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

Join Life Science Leader Chief Editor Ben Comer on April 30th at 11am eastern for the Return of Radiopharmaceuticals: Overcoming Operational Challenges And New Opportunities virtual event. Panelists will discuss emerging technologies and radioisotopes, what new market opportunities exist, and what manufacturing and delivery challenges remain for radiopharmaceutical developers. Registration is free.

To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.

North Carolina’s expanding life sciences infrastructure is creating one of the world’s most integrated supply‑chain hubs and driving major investment across biopharma, agtech, and regulated research.

Uncover how AI-powered extraction and site-centric workflows improve data quality and reduce administrative burdens for research teams.

Automating FDA data validation rules and analyzing audit trail data can significantly reduce fraud and predict areas of concern. Discover how these advancements can transform your clinical trials.

Bispecific antibodies (bsAbs) offer transformative therapeutic potential through dual-target engagement, but their complex structure presents significant manufacturing challenges.

By incorporating flexibility, statistical rigor, and continuous learning, adaptive designs strengthen early-phase oncology programs and support faster, more confident progression into later-stage development.

As companies race to adopt more efficient and environmentally responsible production methods, questions are emerging about how these biological systems work, where they deliver, and what challenges are involved.